CI_PE CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE Angiotensin 2 Receptor Antagonists [MoA] Diabetic Nephropathies [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Heart Failure [Disease/Finding] Hyperaldosteronism [Disease/Finding] Hypertension [Disease/Finding] Hypotension [Disease/Finding] Ventricular Dysfunction, Left [Disease/Finding] telmisartan [Chemical/Ingredient] Decreased Intravascular Volume [PE] Decreased Mineralocorticoid Secretion [PE] Decreased Renal K+ Excretion [PE] Increased Renal Na+ Excretion [PE] Renal Arterial Vasoconstriction [PE] Renal Arterial Vasodilation [PE] Pregnancy [Disease/Finding] T [Preparations] TELMISARTAN <VANDF_Record>50.6^3542^Active/Master</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3542</VA_IEN><VA_Status>Active/Master</VA_Status> C20646 Ingredient 4021146 替米沙坦胶囊 U5SYW473RQ <VANDF_Record>50.416^3818^Active/Master</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3818</VA_IEN><VA_Status>Active/Master</VA_Status> N0000148599 telmisartan 73494 TELMISARTAN C0248719 Decreased Blood Pressure [PE] influenza like illness AE abdominal distension AE anxiety AE upper respiratory tract infection AE infection AE myalgia AE arthralgia AE abdominal pain AE chest pain AE back pain AE dyspepsia AE gastrointestinal disorder AE vertigo AE dry mouth AE skin AE abnormal vision AE diarrhea AE blood uric acid level increased AE hemoglobin level decreased AE hyperhidrosis AE leg pain AE peritendinitis symptom AE leg cramp AE